2.3750
-0.0350
(-1.45%)
As of 3:57:13 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
120,782.0000
113,743.0000
109,184.0000
124,393.0000
155,937.0000
Cost of Revenue
--
--
--
--
100,654.0000
Gross Profit
--
--
--
--
55,283.0000
Operating Expense
127,681.0000
119,871.0000
116,084.0000
125,709.0000
142,902.0000
Operating Income
-6,899.0000
-6,128.0000
-6,900.0000
-1,316.0000
13,035.0000
Net Non Operating Interest Income Expense
-1,171.0000
-1,734.0000
-1,007.0000
-11,313.0000
-7,206.0000
Other Income Expense
1,477.0000
3.0000
1,502.0000
2,403.0000
-27,000.0000
Pretax Income
-8,070.0000
-7,859.0000
-6,405.0000
-10,226.0000
-21,171.0000
Tax Provision
72.0000
-340.0000
132.0000
62.0000
-7,182.0000
Net Income Common Stockholders
-8,142.0000
-7,519.0000
-6,537.0000
-10,288.0000
-13,989.0000
Diluted NI Available to Com Stockholders
-8,142.0000
-7,519.0000
-6,537.0000
-10,288.0000
-13,989.0000
Basic EPS
-0.10
-0.10
-0.09
-0.17
-0.26
Diluted EPS
-0.10
-0.10
-0.09
-0.17
-0.26
Basic Average Shares
77,149.7500
76,156.0000
72,937.0000
60,461.0000
54,414.0000
Diluted Average Shares
77,149.7500
76,156.0000
72,937.0000
60,461.0000
54,414.0000
Total Operating Income as Reported
-6,899.0000
-6,128.0000
-6,900.0000
-1,316.0000
-13,965.0000
Total Expenses
127,681.0000
119,871.0000
116,084.0000
125,709.0000
142,902.0000
Net Income from Continuing & Discontinued Operation
-8,142.0000
-7,519.0000
-6,537.0000
-10,288.0000
-13,989.0000
Normalized Income
-8,144.3700
-7,521.8800
-7,723.5800
-12,042.1900
3,831.0000
Interest Income
414.0000
240.0000
--
--
21.0000
Interest Expense
1,585.0000
1,974.0000
1,007.0000
11,313.0000
7,227.0000
Net Interest Income
-1,171.0000
-1,734.0000
-1,007.0000
-11,313.0000
-7,206.0000
EBIT
-6,485.0000
-5,885.0000
-5,398.0000
1,087.0000
-13,944.0000
EBITDA
568.0000
828.0000
304.0000
8,083.0000
-6,937.0000
Reconciled Cost of Revenue
--
--
--
--
100,654.0000
Reconciled Depreciation
7,053.0000
6,713.0000
5,702.0000
6,996.0000
7,007.0000
Net Income from Continuing Operation Net Minority Interest
-8,142.0000
-7,519.0000
-6,537.0000
-10,288.0000
-13,989.0000
Total Unusual Items Excluding Goodwill
3.0000
3.0000
1,502.0000
2,403.0000
-27,000.0000
Total Unusual Items
3.0000
3.0000
1,502.0000
2,403.0000
-27,000.0000
Normalized EBITDA
565.0000
825.0000
-1,198.0000
5,680.0000
20,063.0000
Tax Rate for Calcs
0.0002
0.0000
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
0.6300
0.1200
315.4200
648.8100
-9,180.0000
12/31/2020 - 8/10/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDRX Veradigm Inc.
7.75
-8.78%
OPRX OptimizeRx Corporation
5.38
-1.01%
EVH Evolent Health, Inc.
10.17
+1.70%
DH Definitive Healthcare Corp.
4.8850
+3.72%
WEAV Weave Communications, Inc.
15.97
+0.82%
CBDS Dogecoin Cash, Inc.
0.0770
+15.11%
HCAT Health Catalyst, Inc.
5.77
+2.77%
PGNY Progyny, Inc.
22.05
+4.26%
PRVA Privia Health Group, Inc.
22.90
+0.97%
CERT Certara, Inc.
13.21
+1.69%